Genky DrugStores Co., Ltd. (TYO:9267)
3,625.00
+45.00 (1.26%)
Aug 6, 2026, 9:53 AM JST
Genky DrugStores Revenue
In the fiscal year ending June 20, 2026, Genky DrugStores had annual revenue of 220.64B JPY with 9.89% growth. Genky DrugStores had revenue of 58.93B in the quarter ending June 20, 2026, with 10.35% growth.
Revenue
220.64B
Revenue Growth
+9.89%
P/S Ratio
0.50
Revenue / Employee
119.85M
Employees
1,841
Market Cap
109.23B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 20, 2026 | 220.64B | 19.85B | 9.89% |
| Jun 20, 2025 | 200.79B | 15.93B | 8.62% |
| Jun 20, 2024 | 184.86B | 15.80B | 9.35% |
| Jun 20, 2023 | 169.06B | 14.42B | 9.32% |
| Jun 20, 2022 | 154.64B | 12.26B | 8.61% |
| Jun 20, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 20, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 20, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cawachi | 285.45B |
| Earth | 182.31B |
| Pola Orbis Holdings | 169.80B |
| MTG Co., Ltd. | 131.24B |
| Pigeon | 111.65B |
| Noevir Holdings | 63.52B |
| Milbon | 54.10B |
| Euglena | 51.63B |